Related references
Note: Only part of the references are listed.PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing L-asparaginase
Yok-Lam Kwong et al.
BLOOD (2017)
Whole blood EBV-DNA: A surrogate for immune dysfunction in aggressive lymphoma?
Qingyan Cui et al.
LEUKEMIA & LYMPHOMA (2016)
A collaborative study to establish the 1st WHO International Standard for Epstein-Barr virus for nucleic acid amplification techniques
Jacqueline F. Fryer et al.
BIOLOGICALS (2016)
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis
Seok Jin Kim et al.
LANCET ONCOLOGY (2016)
Programmed death-1 (PD-1), programmed death-ligand 1 (PD-L1), and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma
Semra Paydas et al.
ANNALS OF HEMATOLOGY (2015)
Radiotherapy and PGEMOX/GELOX regimen improved prognosis in elderly patients with early-stage extranodal NK/T-cell lymphoma
Xi-wen Bi et al.
ANNALS OF HEMATOLOGY (2015)
Epstein-Barr virus-specific CD8+ T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired
D. Cardenas et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age
Ting-Xun Lu et al.
SCIENTIFIC REPORTS (2015)
Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis
Seok Jin Kim et al.
LANCET HAEMATOLOGY (2015)
Quantification of circulating Epstein-Barr virus DNA in NK/T-cell lymphoma treated with the SMILE protocol: diagnostic and prognostic significance
Y-L Kwong et al.
LEUKEMIA (2014)
Combination of gemcitabine, L-asparaginase, and oxaliplatin (GELOX) is superior to EPOCH or CHOP in the treatment of patients with stage IE/IIE extranodal natural killer/T cell lymphoma: a retrospective study in a cohort of 227 patients with long-term follow-up
Wang Liang et al.
MEDICAL ONCOLOGY (2014)
Fasting blood glucose is a novel prognostic indicator for extranodal natural killer/T-cell lymphoma, nasal type
Q. Cai et al.
BRITISH JOURNAL OF CANCER (2013)
First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma
Liang Wang et al.
CANCER (2013)
Serum C-Reactive Protein (CRP) as a Simple and Independent Prognostic Factor in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
Ya-Jun Li et al.
PLOS ONE (2013)
Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK/T-cell lymphoma patients receiving primary radiotherapy
Zhao-Yang Wang et al.
BLOOD (2012)
Pretreatment EBV-DNA Copy Number Is Predictive of Response and Toxicities to SMILE Chemotherapy for Extranodal NK/T-cell Lymphoma, Nasal Type
Yoshinori Ito et al.
CLINICAL CANCER RESEARCH (2012)
Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type
J. J. Huang et al.
ANNALS OF ONCOLOGY (2011)
Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type
Ritsuro Suzuki et al.
BLOOD (2011)
Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study
Motoko Yamaguchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer/T-cell lymphoma
Hyo Song Kim et al.
LEUKEMIA & LYMPHOMA (2009)
Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract
Mei-Juan Huang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
International peripheral T-cell and natural killer/T-cell lymphoma study: Pathology findings and clinical outcomes
Julie M. Vose et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: Elucidating the significance of systemic chemotherapy
Ye Guo et al.
ORAL ONCOLOGY (2008)
Clinical usefulness of serum EBV DNA levels of BamHI W and LMP1 for nasal NK/T-cell lymphoma
Hideyuki Ishii et al.
JOURNAL OF MEDICAL VIROLOGY (2007)
Extranodal natural killer T-cell lymphoma, nasal-type: A prognostic model from a retrospective multicenter study
J Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma
CC Li et al.
CANCER (2004)
Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients
WY Au et al.
BLOOD (2004)
Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index
CS Chim et al.
BLOOD (2004)
Share Paper
